Shilpa Medicare (NSE:SHILPAMED) Interest Expense : ₹-772 Mil (TTM As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Shilpa Medicare Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shilpa Medicare's interest expense for the three months ended in Dec. 2024 was ₹ -117 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-772 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shilpa Medicare's Operating Income for the three months ended in Dec. 2024 was ₹ 519 Mil. Shilpa Medicare's Interest Expense for the three months ended in Dec. 2024 was ₹ -117 Mil. Shilpa Medicare's Interest Coverage for the quarter that ended in Dec. 2024 was 4.42. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shilpa Medicare Interest Expense Historical Data

The historical data trend for Shilpa Medicare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare Interest Expense Chart

Shilpa Medicare Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-45.58

-217.07

-409.34

-562.55

-837.29

Shilpa Medicare Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-262.23	-161.25	-237.38	-255.55	-117.46

Shilpa Medicare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-772 Mil.

Shilpa Medicare (NSE:SHILPAMED) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shilpa Medicare's Interest Expense for the three months ended in Dec. 2024 was ₹-117 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹519 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Shilpa Medicare's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	518.836	/	-117.463
	=	4.42

The higher the ratio, the stronger the company's financial strength is.

Shilpa Medicare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (NSE:SHILPAMED) » Definitions » Interest Expense

Traded in Other Exchanges

530549:India

Address

Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135

Website

https://www.vbshilpa.com

Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines